Feature|Articles|August 29, 2026

Top 5 Spinal Muscular Atrophy Headlines of 2026: What Neurologists Should Know

In honor of SMA Awareness Month, held annually throughout August, get caught up on the latest news in spinal muscular atrophy from 2026, 5 headlines compiled in one place by the NeurologyLive® team.

Spinal muscular atrophy (SMA), a rare neuromuscular disorder, saw regulatory and clinical trial activity across several treatment approaches in 2026, including antisense oligonucleotides (ASOs), gene replacement therapy, and an investigational muscle-directed add-on agent. Below are 5 notable SMA developments from this year so far from the NeurologyLive^® team, in honor of SMA Awareness Month this August.